Family Building FEHB Fairness Act
The Family Building FEHB Fairness Act would amend federal law governing the Federal Employees Health Benefits (FEHB) program to require coverage of fertility treatment benefits. It adds fertility treatment benefits as a covered category under title 5 of the U.S. Code, which sets the rules for the federal employee health insurance program. The bill defines fertility treatment broadly to include preservation of eggs, sperm, and embryos; artificial insemination; assisted reproductive technology such as in vitro fertilization; embryo genetic testing; fertility-related medications; gamete donation; and other related services the Office of Personnel Management (OPM), in coordination with the Department of Health and Human Services, determines appropriate.
The bill would expand access to fertility care for federal employees, retirees, and their covered dependents by making fertility treatment an explicit benefit within FEHB plans. It also directs OPM to work with HHS in identifying additional covered fertility-related services, giving the executive branch some discretion in implementation. The amendments would take effect one year after enactment, giving insurers and administrators time to adjust plan offerings and coverage rules.
Because the bill only amends the FEHB statute, its legal effect is limited to the federal employee health insurance system and does not directly change private insurance mandates or state insurance law. Its practical impact would be on FEHB carriers, federal agencies administering benefits, and enrollees seeking infertility and family-building services. The bill could also influence broader policy discussions about reproductive health coverage and workplace benefits.
There is no recorded committee transcript or vote history in the provided materials, so the general sentiment cannot be measured from debate or roll call data. Based on the bill’s sponsorship and purpose, it appears to be a pro-expansion measure aimed at improving access to fertility care, with no documented opposition in the supplied record. Any contention would likely center on cost, scope of required coverage, and whether services such as IVF, embryo genetic testing, and gamete donation should be mandated as benefits.
The bill would amend section 8904 of title 5, United States Code, to require FEHB plans to include fertility treatment benefits and to define that term broadly. It would affect federal employee health insurance coverage, including plan design, premiums, and covered services, and would take effect one year after enactment. The bill does not directly alter state statutes, but it would expand federally regulated health coverage for federal workers and their families.
No committee discussion or votes were provided, so there is no direct record of support or opposition in the materials. The bill’s text and sponsorship indicate a generally supportive, access-expanding purpose focused on fertility and family-building coverage. In the absence of recorded debate, the available context suggests a favorable policy posture rather than a contested one.
The main likely points of contention are the breadth of the mandated fertility coverage and the associated cost to FEHB plans and enrollees. Specific services that could draw scrutiny include in vitro fertilization, embryo genetic testing, gamete donation, and the inclusion of additional services later determined appropriate by OPM and HHS. Any opposition would likely come from those concerned about insurance premiums, federal benefit mandates, or the scope of reproductive technology coverage.